Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Elston George
Relationship:  
City:   Chatham
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   76,980    

Indirect Shares

  0      
Direct Value   $771,415    

Indirect Value

  $0      
Total Shares   76,980      
Total Value   $771,415      


Celldex Therapeutics Inc
 $750,405 Juniper Pharmaceuticals Inc
 $0 EyePoint Pharmaceuticals Inc
 $21,010 Celldex Therapeutics Inc
 $750,405 Juniper Pharmaceuticals Inc
 $0 EyePoint Pharmaceuticals Inc
 $21,010
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Celldex Therapeutics Inc CLDX Director 2016-06-08 28,500 2009-12-23 0    Premium*  
            Juniper Pharmaceuticals Inc JNP Chief Financial Officer 2016-08-31 1,000 2016-08-31 0    Premium*  
            EyePoint Pharmaceuticals Inc EYPT 2024-05-25 47,480 2019-11-15 0    Premium*  
* Premium Members only  

Records found :    22         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
CLDX Celldex Therapeutics Inc Director   –       •      –    2009-12-23 4 A $0.00 $0 D/D 2,000 2,000 0 -
CLDX Celldex Therapeutics Inc Director   –       •      –    2010-09-22 4 A $0.00 $0 D/D 2,000 2,000 0 -
CLDX Celldex Therapeutics Inc Director   –       •      –    2011-06-22 4 A $0.00 $0 D/D 2,000 2,000 0 -
CLDX Celldex Therapeutics Inc Director   –       •      –    2012-06-20 4 A $0.00 $0 D/D 2,000 8,000 0 -
CLDX Celldex Therapeutics Inc Director   –       •      –    2013-06-19 4 A $0.00 $0 D/D 2,000 10,000 0 -
CLDX Celldex Therapeutics Inc Director   –       •      –    2014-06-04 4 A $0.00 $0 D/D 2,000 12,000 0 -
CLDX Celldex Therapeutics Inc Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 6,500 18,500 0 -
CLDX Celldex Therapeutics Inc Director   –       •      –    2016-06-08 4 A $0.00 $0 D/D 10,000 28,500 0 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2022-02-09 4 OE $0.00 $0 D/D 4,966 11,323 0 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2023-02-09 4 OE $0.00 $0 D/D 10,800 23,116 0 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2024-01-06 4 OE $0.00 $0 D/D 15,285 40,219 0 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2024-02-09 4 OE $0.00 $0 D/D 10,800 46,799 0 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2024-05-25 4 OE $0.00 $0 D/D 7,500 51,107 0 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2020-09-04 4 B $0.48 $4,800 D/D 10,000 40,000 0.01 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2020-08-24 4 B $0.61 $6,112 D/D 10,000 30,000 0.01 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2020-03-12 4 B $0.96 $9,600 D/D 10,000 20,000 0.01 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2019-11-15 4 B $1.43 $14,290 D/D 10,000 10,000 0.01 -
JNP Juniper Pharmaceuticals I... Chief Financial Officer   •       –      –    2016-08-31 4 B $5.50 $5,500 D/D 1,000 1,000 2.74 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2022-02-09 4 D $10.13 $17,434 D/D (1,721) 9,602 0 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2024-05-25 4 D $11.16 $40,477 D/D (3,627) 47,480 0 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2024-01-06 4 D $20.40 $100,184 D/D (4,911) 35,308 0 -
EYPT EyePoint Pharmaceuticals ... Chief Financial Officer   •       –      –    2024-02-09 4 D $28.80 $91,930 D/D (3,192) 43,607 0 -

  22  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed